A new website allows 340B Drug Pricing Program participants to determine the maximum drug companies can charge them for medications sold under the program. The website comes as a result of a recent lawsuit filed against the Health Resources and Services Administration by the American Hospital Association, which sought to force implementation of a final rule impacting drug ceiling prices and civil monetary penalties for manufacturers.